NCT02622386 The Effect of Riboflavin on Moderate to Severe Plaque Type Psoriasis Status COMPLETED Phase PHASE2
NCT02618616 A Study to Determine the Efficacy of ZPL-3893787 in Subjects With Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT02602925 Tight Control Dose Reductions of Biologics in Psoriasis Patients With Low Disease Activity Status COMPLETED Phase PHASE4
NCT02595970 Study to Evaluate Psoriasis Severity and Its Psychosocial Impact Using the Simplified Psoriasis Index (SPI), as Well as Long-term Safety, Tolerability and Efficacy of Secukinumab Administered Subcutaneously in Patients With Moderate to Severe Psoriasis Status COMPLETED Phase PHASE3
NCT02581345 Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis Status COMPLETED Phase PHASE3
NCT02576678 A Study of Safety, Tolerability and Pharmacokinetics of Apremilast (CC-10004) in Pediatric Subjects With Moderate to Severe Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT02576197 Intervention Study to Evaluate a Probiotic in Mild to Moderate Psoriasis Patients Status COMPLETED Phase NA
NCT02574091 Icotinib Hydrochloride Cream in Healthy Adults and Psoriasis Patients Status COMPLETED Phase PHASE1
NCT02572700 Pain Mechanisms and Ultrasonographic Disease Activity in Psoriatic Arthritis Status UNKNOWN Phase N/A
NCT02564042 A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT02559622 Evaluation of Cardiovascular Risk Markers in Psoriasis Patients Treated With Secukinumab Status COMPLETED Phase PHASE3
NCT02555709 An Ascending Multiple Dose Study With VTP-43742 in Healthy Volunteers and Psoriatic Patients Status COMPLETED Phase PHASE1/PHASE2
NCT02550080 Clinical Utility Of Genetic Screening For HLA-B*1301, On Susceptibility To Dapsone Hypersensitivity Syndrome Status UNKNOWN Phase PHASE4
NCT02548052 Study of Safety and Efficacy of Topical GSK2981278 Ointment in Plaque Psoriasis Status COMPLETED Phase PHASE1
NCT02538341 Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial) Status COMPLETED Phase PHASE2
NCT02489643 Individualized Medical Training and Calcipotriol and Betamethasone Dipropionate Gel in Plaque Psoriasis Status COMPLETED Phase NA